Scienture Holdings Stock Is Soaring Thursday: What's Fueling The Momentum?

Shares of Scienture Holdings, Inc. (NASDAQ: SCNX) are rising Thursday after the company announced the start of commercial ...

SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli™ (Losartan Potassium)

Company launches multi-channel promotional campaign to drive market adoption U.S. losartan market totals $256M annually with 71M prescriptions, creating a significant opportunity for Arbli™ as the ...

EXCLUSIVE: Scienture Launches Arbli Oral Suspension, Expanding Options For Hypertension Patients

Scienture launches Arbli, the first FDA-approved liquid losartan, expanding hypertension treatment access across US ...
TipRanks on MSN

Why Did Scienture Stock (SCNX) Soar 45% Today?

Scienture stock was up 46.11% in pre-market trading on Thursday, extending a 10.91% rally yesterday. Even so, SCNX shares ...
Investing.com South Africa

Scienture stock soars as first FDA-approved losartan oral suspension hits market

Investing.com -- Scienture Holdings Inc (NASDAQ:SCNX) stock surged 61.4% after the company announced it has begun commercial sales and fulfillment of the first customer orders for Arbli™, its ...
Stocktwits on MSN

Why Is Scienture Stock Rising Today?

Scienture has commenced selling Arbli, the first FDA-approved ready-to-use liquid losartan formulation. ・The U.S. losartan ...
Blockonomi

Scienture (SCNX) Stock Jumps 355% Following FDA-Approved Arbli Launch

Scienture stock surged 355% on the commercial launch of Arbli, the first FDA-approved liquid losartan, backed by extensive distribution deals.

SCIENTURE’S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers

Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tablets U.S. losartan market totals $256M annually with 71M prescriptions, ...
USA Today

Recalled blood pressure drugs linked to cancer risk OK to take short-term, FDA says

The Food and Drug Administration will allow certain lots of the blood pressure drug losartan that contain trace amounts of a potential carcinogen to be shipped to pharmacies. The temporary measure is ...
Business Wire

Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply

PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots ...
Miami Herald

Another 32 lots of heart and blood pressure medication recalled for possible carcinogen

MacLeods Pharmaceuticals Limited, which recalled one lot of heart and blood pressure medication losartan in February, recalled another 32 lots of losartan Tuesday for the same reason: an impurity that ...
Fox News

Losartan blood pressure medication recall expanded again over cancer concerns, FDA says

Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. In a Sept. 19 statement, ...